Nurse Practitioner in Lower Gwynedd, PA Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Miss Theresa J Davies, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 728 Norristown Rd, Lower Gwynedd, PA 19002 Phone: 215-628-8110 Fax: 215-628-0569 |
Sarah Condon, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 728 Norristown Rd, Lower Gwynedd, PA 19002 Phone: 877-345-5300 |
Kathleen Smith-gomez, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 728 Norristown Rd, Lower Gwynedd, PA 19002 Phone: 877-345-5300 |
Dominique Marques, CRNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 904 Sumneytown Pike Ste 100, Lower Gwynedd, PA 19002 Phone: 215-542-0655 |
Ann Brininger Bunker, CRNP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 728 Norristown Rd, Lower Gwynedd, PA 19002 Phone: 215-628-8110 |
News Archive
Scientists uncover new class of compounds that could help target cancer cells
Scientists from Trinity College Dublin have uncovered a new class of compounds - glyconaphthalimides - that can be used to target cancer cells with greater specificity than current options allow.
'Molecular scissors' could play pivotal role in fighting diseases including HIV infection
One way to fight diseases including HIV infection and autoimmune disorders could involve changing how a naturally occurring enzyme called SAMHD1 works to influence the immune system, new research suggests.
Chronic migraine sufferers experience greater LPT in workplace
A new analysis from the American Migraine Prevalence and Prevention Study, one of the largest longitudinal studies of headache, indicates that employees suffering from Chronic Migraine (CM) experience increased lost productive time (LPT) in the workplace.
Study: Financial stress can have impact on well-being, lead to physical pain in later years
Financial stress can have an immediate impact on well-being, but can it lead to physical pain nearly 30 years later? The answer is yes, according to new research from University of Georgia scientists.
Threshold reports positive results from TH-302 Phase 1/2 clinical trial in pancreatic cancer
Threshold Pharmaceuticals, Inc. today announced updated Phase 1/2 clinical trial results related to the Company's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the ASCO Gastro Intestinal Cancers Symposium that took place in San Francisco from January 20-22, 2011.
› Verified 7 days ago